Orforglipron small molecule, Peptide Customization, 2212020-52-3
- Product Description
Orforglipron small molecule, Peptide Customization, 2212020-52-3:
At Hangzhou Go Top Peptide Biotech Co., Ltd., we're proud to be a leading manufacturer and supplier of Larazotide. Our state-of-the-art facilities and expert team ensure the highest quality product for your pharmaceutical needs. With our commitment to excellence and innovation, we offer unparalleled advantages in peptide synthesis and production.

Product Introduction
The central mechanism of action of oglitazone is based on the activation of the GLP-1 receptor. GLP-1 is a peptide hormone secreted by human intestinal cells. It is released after eating and can participate in a variety of physiological processes such as blood glucose regulation. By binding to the GLP-1 receptor and simulating the action of GLP-1, oglitazone exerts its efficacy in multiple dimensions.
Key Product Details
1.CAS: 2212020-52-3
2.Sequence: //
3.Molecular formula: C48H48F2N10O5
4.Molecular weight: 882.97

Specifications
Parameter | Specification |
Appearance | White to off-white powder |
Purity | ≥98% |
Solubility | Soluble in water |
Storage | -20°C, protected from light |
Uses and Applications
Orforglipron small molecule, Peptide Customization, 2212020-52-3 has shown promise in:
1. It stimulates insulin release from pancreatic beta cells. Insulin is a key hormone to regulate blood glucose. It can promote the uptake and utilization of glucose in the blood by various tissues of the body, such as muscle, fat and liver, so as to effectively reduce blood glucose levels. Moreover, the "smart" property of ogaglione to stimulate insulin secretion only acts when blood glucose is elevated (such as after eating), and its stimulating effect is weakened when blood glucose is in the normal range, which greatly reduces the risk of hypoglycemia and makes blood glucose regulation more precise and safe.
2. Ogagliflozin can inhibit glucagon secretion by islet α-cells. Glucagon, which has the opposite effect of insulin, prompts the liver to release glucose into the blood, causing blood sugar to rise. By inhibiting glucagon secretion, ogagliflozin further reduces endogenous glucose production and controls the rise in blood glucose at its source.

Company Introduction
Hangzhou Go Top Peptide Biotech Co., Ltd. is a global leader in peptide synthesis and manufacturing. We combine cutting-edge technology with scientific expertise to deliver high-quality peptides for pharmaceutical research and development.
Our Advantages
1.GMP-certified production facilities
2.Rigorous quality control systems
3.Fast turnaround times
4.Global delivery network
5.Cost-effective solutions
6.Comprehensive technical support
Laboratory and Factory
Our state-of-the-art laboratory and factory are equipped with the latest peptide synthesis technology. Our facilities adhere to strict quality standards, ensuring consistent, high-purity Larazotide production.

Packaging and Shipping
We offer secure, temperature-controlled packaging to maintain product integrity. Our global logistics network ensures timely delivery to your facility, wherever you are in the world.
Certification
Hangzhou Go Top Peptide Biotech Co., Ltd. is proud to have passed ISO 9001:2015 quality management system certification, demonstrating our commitment to excellence and regulatory compliance.

FAQ
1.Which end is best for my research?
By default, the peptide ends with an N-terminal free amino group and a C-terminal free carboxyl group. The peptide sequence often represents the sequence of the mother protein. In order to be closer to the mother protein, the end of the peptide often needs to be closed, that is, n-terminal acetylation and C-terminal amidation. This modification avoids the introduction of excess charge, and also makes it more able to prevent exonucliase action, so that the peptide is more stable.
2.Which modified labeled polypeptides can be synthesized in Chinese peptide?
Our company provides a variety of modified peptide labeling, such as acetylation, biotin labeling, phosphorylation modification, fluorescence modification, can also be customized according to your special needs.
3.How do you dissolve polypeptides?
The solubility of polypeptide depends mainly on its primary and secondary structure, the nature of modification label, solvent type and final concentration. If the peptide is insoluble in water, ultrasound can help dissolve it. For basic peptide, it is recommended to dissolve with 10% acetic acid; For acidic peptides, dissolution with 10%NH4HCO3 is recommended. Organic solvents can also be added to insoluble polypeptides. The peptide is dissolved in the least amount of organic solvent (e.g., DMSO, DMF, isopropyl alcohol, methanol, etc.). It is highly recommended that the peptide be dissolved in the organic solvent first and then slowly added to water or other buffer until the desired concentration.
Contact Us
Ready to order or have questions about our Larazotide? We're here to help! Contact our expert team at sales1@gotopbio.com for personalized assistance and to discuss how we can meet your peptide needs.
Experience the Hangzhou Go Top Peptide Biotech difference – where quality, innovation, and customer satisfaction meet. Let's advance gastrointestinal health research together with our premium product.




